US, ex rel. Pacira BioSciences, Inc. v. QuVa Pharma, Inc., et al
Plaintiff: UNITED STATES, EX REL. PACIRA BIOSCIENCES, INC. and UNITED STATES, ex rel.
Defendant: QUVA PHARMA, INC., VENTIS PHARMA, INC., NUBRATORI, INC., d/b/a Nubratori RX, NEPHRON STERILE COMPOUNDING CENTER, LLC, W. BRADLEY WORTHINGTON, NEPHRON PHARMACEUTICALS CORPORATION and INFUSYSTEM HOLDINGS, INC.
Case Number: 25-1973
Filed: October 21, 2025
Court: U.S. Court of Appeals, First Circuit
Nature of Suit: Qui Tam False Claims Act
Docket Report

This docket was last retrieved on April 8, 2026. A more recent docket listing may be available from PACER.

Date Filed Document Text
April 8, 2026 Opinion or Order ORDER entered: Upon consideration, Appellee Ventis Pharma, Inc.'s notice of withdrawal of pro hac vice motion is construed as a motion to withdraw the motion for pro hac vice admission filed on February 25, 2026, and is granted. [25-1973] (JW) [Entered: 04/08/2026 04:49 PM]
April 6, 2026 NOTICE of Withdrawal of Pro Hac Vice Motion filed by Appellee Ventis Pharma, Inc.. Served on 04/06/2026. [25-1973] (LVC) [Entered: 04/06/2026 03:07 PM]
March 19, 2026 Opinion or Order ORDER granting motion to extend time to file brief filed by Appellees Nephron Sterile Compounding Center, LLC, QuVa Pharma, Inc. and Ventis Pharma, Inc. Brief due 04/29/2026 for appellees Nephron Sterile Compounding Center, LLC, QuVa Pharma, Inc. and Ventis Pharma, Inc. [25-1973] (JW) [Entered: 03/19/2026 02:32 PM]
March 19, 2026 AMENDED MOTION to extend time to file brief filed by Appellees Ventis Pharma, Inc., QuVa Pharma, Inc. and Nephron Sterile Compounding Center, LLC. Served on 03/19/2026. [25-1973] (LVC) [Entered: 03/19/2026 01:11 PM]
March 13, 2026 MOTION to extend time to file brief filed by Appellees Ventis Pharma, Inc., QuVa Pharma, Inc. and Nephron Sterile Compounding Center, LLC. Served on 03/13/2026. [25-1973] (LVC) [Entered: 03/13/2026 01:49 PM]
March 6, 2026 FIVE (5) paper copies of joint appendix [ # 6790366-2 ] submitted by Appellant Pacira BioSciences, Inc. [25-1973] (SRS) [Entered: 03/13/2026 09:22 AM]
March 6, 2026 NINE (9) paper copies of appellant's brief [ # 6790359-2 ] submitted by Appellant Pacira BioSciences, Inc. [25-1973] (SRS) [Entered: 03/13/2026 09:03 AM]
March 3, 2026 APPELLANT'S BRIEF filed by Appellant Pacira BioSciences, Inc. Served on 02/27/2026. Nine paper copies identical to that of the electronically filed brief must be submitted so that they are received by the court on or before 03/10/2026 . Brief(s) due 03/30/2026 for APPELLEES Nephron Sterile Compounding Center, LLC, Nubratori, Inc., QuVa Pharma, Inc., Ventis Pharma, Inc. and W. Bradley Worthington. [25-1973] (YCC) [Entered: 03/03/2026 04:54 PM]
March 3, 2026 JOINT APPENDIX filed by Appellant Pacira BioSciences, Inc. Number of volumes: 2. Served on 02/27/2026. Five paper copies of the electronically filed appendix must be submitted so that they are received by the court on or before 03/10/2026 . [25-1973] (YCC) [Entered: 03/03/2026 04:59 PM]
March 3, 2026 DISCLOSURE statement filed by Appellant Pacira BioSciences, Inc. Served on 02/27/2026. [25-1973] (YCC) [Entered: 03/03/2026 05:01 PM]
February 27, 2026 APPENDIX tendered by Appellant Pacira BioSciences, Inc. and Appellees QuVa Pharma, Inc., Ventis Pharma, Inc., Nubratori, Inc. and Nephron Sterile Compounding Center, LLC. Served on 02/27/2026. [25-1973] (PAW) [Entered: 02/27/2026 03:05 PM]
February 27, 2026 BRIEF tendered by Appellant Pacira BioSciences, Inc.. [25-1973] (PAW) [Entered: 02/27/2026 03:01 PM]
February 25, 2026 MOTION FOR PRO HAC VICE ADMISSION OF CARRIE RICHEY filed by Appellee Ventis Pharma, Inc.. Served on 02/25/2026. [25-1973] (LVC) [Entered: 02/25/2026 05:02 PM]
February 25, 2026 DISCLOSURE statement filed by Appellee Ventis Pharma, Inc.. Served on 02/25/2026. [25-1973] (LVC) [Entered: 02/25/2026 04:55 PM]
February 25, 2026 NOTICE of appearance on behalf of Appellee Ventis Pharma, Inc. filed by Attorney Luke V. Cass. Served on 02/25/2026. [25-1973] (LVC) [Entered: 02/25/2026 04:53 PM]
February 25, 2026 NOTICE of appearance on behalf of Appellant Pacira BioSciences, Inc. filed by Attorney Ryan Michael D'Ercole. Served on 02/25/2026. [25-1973] (RMD) [Entered: 02/25/2026 03:16 PM]
February 6, 2026 Opinion or Order ORDER granting motion to extend time to file brief and appendix filed by Appellant Pacira BioSciences, Inc. Brief and Appendix due 02/27/2026 for appellant Pacira BioSciences, Inc. We are disinclined to grant a request for further enlargement of this deadline. [25-1973] (JW) [Entered: 02/06/2026 04:52 PM]
February 5, 2026 MOTION to extend time to file brief and appendix filed by Appellant Pacira BioSciences, Inc.. Served on 02/05/2026. [25-1973] (PAW) [Entered: 02/05/2026 11:46 AM]
December 15, 2025 NOTICE of appearance on behalf of Appellant Pacira BioSciences, Inc. filed by Attorney Scott Liebman. Served on 12/15/2025. [25-1973] (SSL) [Entered: 12/15/2025 01:41 PM]
December 9, 2025 Opinion or Order ORDER entered: Upon consideration of the December 5, 2025 joint motion, Appellant Pacira BioSciences, Inc.'s brief and appendix are to be filed on, or before, February 13, 2026 . To the extent the motion seeks to extend the other briefing deadlines, motion is denied without prejudice as premature because the appellant's principal brief has not been accepted for filing. See Fed. R. App. P. 31(a)(1) and 1st Cir. 31.0(a)(1). [25-1973] (JW) [Entered: 12/09/2025 03:49 PM]
December 8, 2025 NOTICE issued. The following attorneys have failed to register for an appellate ECF account and will no longer receive notice of court issued documents in this case: Sara Mary Bauer for Ventis Pharma, Inc. and Nubratori, Inc., Jasmine Chalashtori for Ventis Pharma, Inc. and Nubratori, Inc., Jennifer Lee Cluverius for Nephron Sterile Compounding Center, LLC, Jed Matthew Nosal for Ventis Pharma, Inc. and Nubratori, Inc., Carrie Richey for Ventis Pharma, Inc. and Nubratori, Inc., Stephanie S. Riley for Ventis Pharma, Inc. and Nubratori, Inc., Benjamin Rosen for Nephron Sterile Compounding Center, LLC, Judith Samilda Araujo for InfuSystem Holdings, Inc., Erin Colleran for US, William A. Scofield for InfuSystem Holdings, Inc., Natalie Waites for US and Jamie Ann Yavelberg for US. [25-1973] (JW) [Entered: 12/08/2025 08:20 PM]
December 5, 2025 MOTION to extend time to file brief and appendix to extend time to file a response filed by Appellant Pacira BioSciences, Inc. and Appellees Nephron Sterile Compounding Center, LLC, QuVa Pharma, Inc. and W. Bradley Worthington. Served on 12/05/2025. [25-1973] (PAW) [Entered: 12/05/2025 04:30 PM]
November 25, 2025 NOTICE of appearance on behalf of Appellee QuVa Pharma, Inc. filed by Attorney Christian Sheehan. Served on 11/25/2025. [25-1973] (CDS) [Entered: 11/25/2025 01:26 PM]
November 13, 2025 NOTICE issued. After 11/28/2025, the following attorneys will no longer receive notice of court issued documents in this case unless they register for an appellate ECF account: Scott Liebman for Pacira BioSciences, Inc., Sara Mary Bauer for Ventis Pharma, Inc. and Nubratori, Inc., Jasmine Chalashtori for Ventis Pharma, Inc. and Nubratori, Inc., Jennifer Lee Cluverius for Nephron Sterile Compounding Center, LLC, Jed Matthew Nosal for Ventis Pharma, Inc. and Nubratori, Inc., Carrie Richey for Ventis Pharma, Inc. and Nubratori, Inc., Stephanie S. Riley for Ventis Pharma, Inc. and Nubratori, Inc., Benjamin Rosen for Nephron Sterile Compounding Center, LLC, Christian D. Sheehan for QuVa Pharma, Inc., Judith Samilda Araujo for InfuSystem Holdings, Inc., David Barnard for InfuSystem Holdings, Inc., Erin Colleran for US, William A. Scofield for InfuSystem Holdings, Inc., Natalie Waites for US and Jamie Ann Yavelberg for US. [25-1973] (JW) [Entered: 11/13/2025 05:16 PM]
November 13, 2025 BRIEFING schedule set. Brief and Appendix due 12/23/2025 for appellant Pacira BioSciences, Inc. Pursuant to F.R.A.P. 31(a), appellee's brief will be due 30 days following service of appellant's brief and appellant's reply brief will be due 21 days following service of appellee's brief. [25-1973] (JW) [Entered: 11/13/2025 04:56 PM]
November 5, 2025 NOTICE of appearance on behalf of Appellant Pacira Biosciences, Inc. filed by Attorney Peter E. Gelhaar. Served on 11/05/2025. [25-1973] (PEG) [Entered: 11/05/2025 03:45 PM]
November 4, 2025 NOTICE of appearance on behalf of Appellant Pacira Biosciences, Inc. filed by Attorney Imad Matini. Served on 11/04/2025. [25-1973] (ISM) [Entered: 11/04/2025 04:40 PM]
November 4, 2025 NOTICE of appearance on behalf of Appellee QuVa Pharma, Inc. filed by Attorney Allon Kedem. Served on 11/04/2025. [25-1973] (AK) [Entered: 11/04/2025 11:56 AM]
November 4, 2025 DISCLOSURE statement filed by Appellee QuVa Pharma, Inc.. Served on 11/04/2025. [25-1973] (MAR) [Entered: 11/04/2025 11:50 AM]
November 4, 2025 NOTICE of appearance on behalf of Appellee QuVa Pharma, Inc. filed by Attorney Debra E. Schreck. Served on 11/04/2025. [25-1973] (DES) [Entered: 11/04/2025 11:52 AM]
November 4, 2025 NOTICE of appearance on behalf of Appellee QuVa Pharma, Inc. filed by Attorney Joshua S. Barlow. Served on 11/04/2025. [25-1973] (JSB) [Entered: 11/04/2025 11:54 AM]
November 4, 2025 NOTICE of appearance on behalf of Appellant Pacira Biosciences, Inc. filed by Attorney Christopher Bauer. Served on 11/04/2025. [25-1973] (CLB) [Entered: 11/04/2025 04:45 PM]
November 4, 2025 NOTICE of appearance on behalf of Appellee Nephron Sterile Compounding Center, LLC filed by Attorney John Neiman. Served on 11/04/2025. [25-1973] (JCN) [Entered: 11/04/2025 02:06 PM]
November 4, 2025 NOTICE of appearance on behalf of Appellant Pacira Biosciences, Inc. filed by Attorney A Joseph Jay. Served on 11/04/2025. [25-1973] (AJJ) [Entered: 11/04/2025 04:42 PM]
November 4, 2025 NOTICE of appearance on behalf of Appellant Pacira Biosciences, Inc. filed by Attorney Angelo Pavone. Served on 11/04/2025. [25-1973] (AAP) [Entered: 11/04/2025 04:49 PM]
November 4, 2025 NOTICE of appearance on behalf of Appellee QuVa Pharma, Inc. filed by Attorney Michael A. Rogoff. Served on 11/04/2025. [25-1973] (MAR) [Entered: 11/04/2025 11:49 AM]
November 3, 2025 DOCKETING statement filed by Appellant Pacira Biosciences, Inc.. Served on 11/03/2025. [25-1973] (PAW) [Entered: 11/03/2025 04:07 PM]
November 3, 2025 NOTICE of appearance on behalf of Appellant Pacira Biosciences, Inc. filed by Attorney Paul Werner. Served on 11/03/2025. [25-1973] (PAW) [Entered: 11/03/2025 04:05 PM]
November 3, 2025 TRANSCRIPT report/order form filed by Appellant Pacira Biosciences, Inc. indicating all necessary transcripts have already been filed in district court. Served on 11/03/2025. [25-1973] (PAW) [Entered: 11/03/2025 04:08 PM]
October 21, 2025 CIVIL CASE docketed. Notice of appeal (doc. #154) filed by Appellant Pacira Biosciences, Inc.. Docketing Statement due 11/04/2025. Transcript Report/Order form due 11/04/2025. Appearance form due 11/04/2025. [25-1973] (AL) [Entered: 10/21/2025 08:41 PM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.

Search for this case: US, ex rel. Pacira BioSciences, Inc. v. QuVa Pharma, Inc., et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: UNITED STATES, EX REL. PACIRA BIOSCIENCES, INC.
Represented By: Paul Anthony Werner III
Represented By: Angelo Amir Pavone
Represented By: Imad Sayed Matini
Represented By: Lisa Marie Lewis
Represented By: Anthony Joseph Jay III
Represented By: Peter E. Gelhaar
Represented By: Christopher Lee Bauer
Represented By: Scott S. Liebman
Represented By: Ryan Michael D'Ercole
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: UNITED STATES, ex rel.
Represented By: Jamie Ann Yavelberg
Represented By: Natalie Waites
Represented By: Diane Seol
Represented By: Donald Campbell Lockhart
Represented By: Brian M. LaMacchia
Represented By: Abraham R. George
Represented By: Erin Colleran
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: QUVA PHARMA, INC.
Represented By: Christian D. Sheehan
Represented By: Debra E. Schreck
Represented By: Michael A. Rogoff
Represented By: Joshua S. Barlow
Represented By: Allon Kedem
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: VENTIS PHARMA, INC.
Represented By: Stephanie S. Riley
Represented By: Carrie Richey
Represented By: Jed Matthew Nosal
Represented By: Jasmine Chalashtori
Represented By: Sara Mary Bauer
Represented By: Luke Verrill Cass
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: NUBRATORI, INC., d/b/a Nubratori RX
Represented By: Stephanie S. Riley
Represented By: Carrie Richey
Represented By: Jed Matthew Nosal
Represented By: Jasmine Chalashtori
Represented By: Sara Mary Bauer
Represented By: Luke Verrill Cass
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: NEPHRON STERILE COMPOUNDING CENTER, LLC
Represented By: Erica Williamson Barnes
Represented By: Nikole Setzler Mergo
Represented By: Benjamin Rosen
Represented By: Jennifer Lee Cluverius
Represented By: John C. Neiman Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: W. BRADLEY WORTHINGTON
Represented By: W. Bradley Worthington
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: NEPHRON PHARMACEUTICALS CORPORATION
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: INFUSYSTEM HOLDINGS, INC.
Represented By: William A. Scofield
Represented By: David Barnard
Represented By: Judith Samilda Araujo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?